Advisory: Alert on Eiger Biopharmaceuticals from law firm withdrawn
28/11/2022 22:14
An alert on Eiger Biopharmaceuticals Inc EIGR.O from a law
firm has been withdrawn as it was issued inadvertently.
There will be no substitute.
STORY_NUMBER: TUA4CPTTX
STORY_DATE: 28/11/2022
STORY_TIME: 10:00:41
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview